Bloomberg News quoted Susan Domchek, MD, executive director of the Basser Research Center for BRCA in article on Jolie’s decision:
Jolie Mastectomy Fuels Debate on Breast Cancer Treatment
Those two paths, each with risks and benefits, can leave patients confused and conflicted over how best to protect themselves, said Susan Domchek, a breast cancer researcher and director of the Basser Research Center at the University of Pennsylvania. Jolie said she chose to have a double mastectomy after learning she had the genetic mutation that increased her risk for cancer, which killed her mother. Read more at Bloomberg here.
Domchek was also quoted in a Philadelphia Inquirer piece on Angelina Jolie’s op-ed on carrying a BRCA1mutation and opting for a double mastectomy:
Jolie’s Difficult Medical Decision Wins Praise
"It's not the magic solution," Domchek said. "But it's a compelling example of how, if you know the biology of the cancer, you can use it." Read more at Philly.com here.
6 ABC also quoted the Basser executive director in an article about Jolie’s decision to get preventive mastectomies:
Understanding Angelina Jolie’s Decision
Dr. Susan Domchek of the University of Pennsylvania's Basser Research Center for BRCA, says easy access to information, and a wider range of reconstruction options figure are factors in the rise. Read more at 6 ABC here.
For the latest information on BRCA research,
screening and clinical trials from
The Basser Research Center for BRCA,
visit the official webpage.
screening and clinical trials from
The Basser Research Center for BRCA,
visit the official webpage.
0 comments:
Post a Comment